Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy
By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment. A study…